Jaime Prat

Universitat Autònoma de Barcelona

Papers

2

Total Citations

385

H-Index

2

About

Jaime Prat is a towering figure in gynecologic oncology, whose work has fundamentally shaped the understanding and clinical management of ovarian cancer. His primary research focuses on the pathology and treatment of epithelial and non-epithelial ovarian tumors, with a particular emphasis on borderline tumors and fertility-sparing approaches. Prat’s most influential contribution is his leadership in developing the ESMO Clinical Practice Guidelines for non-epithelial ovarian cancer, a landmark paper cited over 365 times that provides a standardized framework for diagnosis, treatment, and follow-up—directly improving patient outcomes worldwide. He has also advanced the nuanced care of borderline ovarian tumors, demonstrating through his 2014 study that conservative, fertility-sparing surgery outcomes vary significantly by patient age and histological subtype, a critical insight for young women facing cancer. With a career spanning decades, Prat has been a driving force in integrating pathological classification with clinical decision-making, earning him international recognition as a pioneer. His work remains essential reading for oncologists and researchers, bridging the gap between laboratory findings and compassionate, effective patient care.

Research Focus

Key Achievements

2
H-Index
2
Papers
385
Total Citations
193
Avg Citations/Paper
🏆 Most Cited Paper
Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
365 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Universitat Autònoma de Barcelona

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago